EUVIMEDEUVIMED entdecken
Crossref

Label-free integrated microfluidic plasmonic biosensor from vertical-cavity surface-emitting lasers for SARS-CoV-2 receptor binding domain protein detection

Wenhui Jiang, Zhengtai Ma, Fang Cao, Liangchen Hu, Lei Bao, Pengying Chang, Chen Xu, Xiaoqing Lv, Yiyang Xie

Optics Express · 2023

DOI: 10.1364/oe.486605 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Optics Express, 2023. Verfasst von Wenhui Jiang und 8 weiteren Autor:innen. Hauptthemen laut MEDLINE: COVID-19, Biosensing Techniques. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 36 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Beijing Municipal Natural Science Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The nanoplasmonic sensor of the nanograting array has a remarkable ability in label-free and rapid biological detection. The integration of the nanograting array with the standard vertical-cavity surface-emitting lasers (VCSEL) platform can achieve a compact and powerful solution to provide on-chip light sources for biosensing applications. Here, a high sensitivity and label-free integrated VCSELs sensor was developed as a suitable analysis technique for COVID-19 specific receptor binding domain (RBD) protein. The gold nanograting array is integrated on VCSELs to realize the integrated microfluidic plasmonic biosensor of on-chip biosensing. The 850 nm VCSELs are used as a light source to excite the localized surface plasmon resonance (LSPR) effect of the gold nanograting array to detect the concentration of attachments. The refractive index sensitivity of the sensor is 2.99 × 10 6 nW/RIU. The aptamer of RBD was modified on the surface of the gold nanograting to detect the RBD protein successfully. The biosensor has high sensitivity and a wide detection range of 0.50 ng/mL – 50 µg/mL. This VCSELs biosensor provides an integrated, portable, and miniaturized idea for biomarker detection.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Biosensing TechniquesHumansMicrofluidicsSARS-CoV-2Carrier ProteinsSurface Plasmon ResonanceLasersGold

Substanzen

Carrier ProteinsGold

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Beijing Municipal Natural Science Foundation
  • Beijing Nova Program

Zitieren

APA

Jiang, W., Ma, Z., Cao, F., Hu, L., Bao, L., Chang, P., Xu, C., Lv, X., & Xie, Y. (2023). Label-free integrated microfluidic plasmonic biosensor from vertical-cavity surface-emitting lasers for SARS-CoV-2 receptor binding domain protein detection. Optics Express. https://doi.org/10.1364/oe.486605

Vancouver

Jiang W, Ma Z, Cao F, Hu L, Bao L, Chang P, et al. Label-free integrated microfluidic plasmonic biosensor from vertical-cavity surface-emitting lasers for SARS-CoV-2 receptor binding domain protein detection. Optics Express. 2023. doi:10.1364/oe.486605

BibTeX
@article{Jiang2023,
  author = {Jiang, Wenhui and Ma, Zhengtai and Cao, Fang and Hu, Liangchen and Bao, Lei and Chang, Pengying and Xu, Chen and Lv, Xiaoqing and Xie, Yiyang},
  title = {Label-free integrated microfluidic plasmonic biosensor from vertical-cavity surface-emitting lasers for SARS-CoV-2 receptor binding domain protein detection},
  journal = {Optics Express},
  year = {2023},
  doi = {10.1364/oe.486605}
}
Kostenlos starten →